Suivre
Johanna C Meyer
Johanna C Meyer
Professor, School of Pharmacy; Head: SAVIC; Sefako Makgatho Health Sciences University
Adresse e-mail validée de smu.ac.za - Page d'accueil
Titre
Citée par
Citée par
Année
Response to the novel corona virus (COVID-19) pandemic across Africa: successes, challenges, and implications for the future
OO Ogunleye, D Basu, D Mueller, J Sneddon, RA Seaton, ...
Frontiers in pharmacology 11, 1205, 2020
2322020
Strategies to improve antimicrobial utilization with a special focus on developing countries
B Godman, A Egwuenu, M Haque, OO Malande, N Schellack, S Kumar, ...
Life 11 (6), 528, 2021
2092021
Ongoing initiatives to improve the quality and efficiency of medicine use within the public healthcare system in South Africa; a preliminary study
JC Meyer, N Schellack, J Stokes, R Lancaster, H Zeeman, D Defty, ...
Frontiers in pharmacology 8, 751, 2017
1952017
Barriers for access to new medicines: searching for the balance between rising costs and limited budgets
B Godman, A Bucsics, P Vella Bonanno, W Oortwijn, CC Rothe, A Ferrario, ...
Frontiers in Public Health 6, 328, 2018
1852018
Ongoing strategies to improve the management of upper respiratory tract infections and reduce inappropriate antibiotic use particularly among lower and middle-income countries …
B Godman, M Haque, J McKimm, M Abu Bakar, J Sneddon, J Wale, ...
Current medical research and opinion 36 (2), 301-327, 2020
1722020
Medicine shortages and challenges with the procurement process among public sector hospitals in South Africa; findings and implications
C Modisakeng, M Matlala, B Godman, JC Meyer
BMC health services research 20, 1-10, 2020
1462020
Review of ongoing activities and challenges to improve the care of patients with type 2 diabetes across Africa and the implications for the future
B Godman, D Basu, Y Pillay, JC Mwita, GM Rwegerera, ...
Frontiers in pharmacology 11, 108, 2020
1382020
Fixed dose drug combinations–are they pharmacoeconomically sound? Findings and implications especially for lower-and middle-income countries
B Godman, H McCabe, T D Leong, D Mueller, AP Martin, I Hoxha, ...
Expert review of pharmacoeconomics & outcomes research 20 (1), 1-26, 2020
1042020
Tackling antimicrobial resistance across sub-Saharan Africa: Current challenges and implications for the future
B Godman, A Egwuenu, E Wesangula, N Schellack, AC Kalungia, ...
Expert Opinion on Drug Safety 21 (8), 1089-1111, 2022
832022
Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications
B Godman, A Hill, S Simoens, G Selke, I Selke Krulichová, ...
Expert review of pharmacoeconomics & outcomes research 21 (4), 527-540, 2021
762021
A situational analysis of current antimicrobial governance, regulation, and utilization in South Africa
N Schellack, D Benjamin, A Brink, A Duse, K Faure, D Goff, M Mendelson, ...
International journal of infectious diseases 64, 100-106, 2017
752017
Identifying medication errors in the neonatal intensive care unit and paediatric wards using a medication error checklist at a tertiary academic hospital in Gauteng, South Africa
A Truter, N Schellack, JC Meyer
South African Journal of Child Health 11 (1), 5-10, 2017
722017
Randomized, controlled trial of prescribing training in a South African province
JC Meyer, RS Summers, H Möller
Medical education 35 (9), 833-840, 2001
632001
Knowledge and perceptions of antimicrobial stewardship concepts among final year pharmacy students in pharmacy schools across South Africa
M Burger, J Fourie, D Loots, T Mnisi, N Schellack, S Bezuidenhout, ...
Southern African Journal of Infectious Diseases 31 (3), 27-33, 2016
612016
Challenges and innovations brought about by the COVID-19 pandemic regarding medical and pharmacy education especially in Africa and implications for the future
A Etando, AA Amu, M Haque, N Schellack, A Kurdi, AA Alrasheedy, ...
Healthcare 9 (12), 1722, 2021
582021
Ongoing efforts to improve antimicrobial utilization in hospitals among African countries and implications for the future
Z Saleem, B Godman, A Cook, MA Khan, SM Campbell, RA Seaton, ...
Antibiotics 11 (12), 1824, 2022
562022
Knowledge, attitudes and practices of health care professionals towards adverse drug reaction reporting in public sector primary health care facilities in a South African district
HM Haines, JC Meyer, RS Summers, BB Godman
European journal of clinical pharmacology 76 (7), 991-1001, 2020
562020
Ongoing and planned activities to improve the management of patients with Type 1 diabetes across Africa; implications for the future
B Godman, D Basu, Y Pillay, PHRF Almeida, JC Mwita, GM Rwegerera, ...
Hospital practice 48 (2), 51-67, 2020
562020
A point prevalence survey of antimicrobial utilisation patterns and quality indices amongst hospitals in South Africa; findings and implications
PP Skosana, N Schellack, B Godman, A Kurdi, M Bennie, D Kruger, ...
Expert review of anti-infective therapy 19 (10), 1353-1366, 2021
542021
Compliance with the primary health care treatment guidelines and the essential medicines list in the management of sexually transmitted infections in correctional centres in …
TB Matsitse, E Helberg, JC Meyer, B Godman, A Massele, N Schellack
Expert review of anti-infective therapy 15 (10), 963-972, 2017
542017
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20